| Schedule of Intangible Assets |
Intangible assets were as follows as of May 31, 2026 and November 30, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
Useful lives |
|
May 31, 2026 |
|
|
November 30, 2025 |
|
Patents |
|
10-20 years |
|
$ |
697,744 |
|
|
$ |
697,744 |
|
Less: Intangible asset impairment |
|
|
|
|
(377,810 |
) |
|
|
(377,810 |
) |
Less: Accumulated amortization |
|
|
|
|
(189,494 |
) |
|
|
(183,682 |
) |
License agreement |
|
10 years |
|
|
474,000 |
|
|
|
474,000 |
|
Less: Intangible asset impairment |
|
|
|
|
(185,000 |
) |
|
|
(185,000 |
) |
Less: Accumulated amortization |
|
|
|
|
(285,917 |
) |
|
|
(285,818 |
) |
Customer relationships – PrepaCyte®CB |
|
15 years |
|
|
41,000 |
|
|
|
41,000 |
|
Less: Intangible asset impairment |
|
|
|
|
(26,267 |
) |
|
|
(26,267 |
) |
Less: Accumulated amortization |
|
|
|
|
(11,491 |
) |
|
|
(11,093 |
) |
Brand |
|
1 year |
|
|
31,000 |
|
|
|
31,000 |
|
Less: Accumulated amortization |
|
|
|
|
(31,000 |
) |
|
|
(31,000 |
) |
Customer relationships – Cord:Use |
|
30 years |
|
|
960,000 |
|
|
|
960,000 |
|
Less: Accumulated amortization |
|
|
|
|
(256,000 |
) |
|
|
(240,000 |
) |
Net Intangible Assets |
|
|
|
$ |
840,765 |
|
|
$ |
863,074 |
|
|